{"SPADE_UN_17434": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17434", "Peptide Name": "Gomesin [PYA1E]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "ECRRLCYKQRCVTYCRGR", "Sequence Length": 18, "UniProt Entry": ["http://www.uniprot.org/uniprot/P82358"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "", "N-terminal Modification": "Amidation", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C93H157N35O25S4", "Mass": 2293.72, "PI": 9.58, "Net Charge": 5, "Hydrophobicity": -1.06, "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour", "Literature": [{"Title": "Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation", "Pubmed ID": "30068931", "Reference": "Sci Rep. 2018 Aug 1;8(1)11520.", "Author": "Ikonomopoulou MP, Fernandez-Rojo MA, Pineda SS, Cabezas-Sainz P, Winnen B, Morales RAV, Brust A, SÃ¡nchez L, Alewood PF, Ramm GA, Miles JJ, King GF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30068931"}], "Frequent Amino Acids": "RCY", "Absent Amino Acids": "ADFHIMNOPSUW", "Basic Residues": 6, "Acidic Residues": 1, "Hydrophobic Residues": 4, "Polar Residues": 15, "Positive Residues": 6, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02789", "Similarity": 1.0, "Sequence": "CRRLCYKQRCVTYCRGR"}, {"SPADE_ID": "SPADE_N_03752", "Similarity": 1.0, "Sequence": "CRRLCYKQRCVTYCRGR"}, {"SPADE_ID": "SPADE_N_03753", "Similarity": 1.0, "Sequence": "CRRLCYKQRCVTYCRG"}]}}}